Nimit Singhal

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Prevalence and factors associated with polypharmacy in older people with cancer

Justin P. Turner, Sepehr Shakib, Nimit Singhal et al. · Supportive Care in Cancer · 2014 · 145 citations

Medicine, Geriatric Medicine, Oncology +12

International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

Sally Wheelwright, Deborah Fitzsimmons, Peter Fayers et al. · British Journal of Cancer · 2013 · 131 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Polypharmacy cut-points in older people with cancer: how many medications are too many?

Justin P. Turner, Kris M. Jamsen, Sepehr Shakib et al. · Supportive Care in Cancer · 2015 · 130 citations

Pharmacy, Oncology, Pharmacotherapy +16